Brind.

An Executive Order has been issued mandating accelerated research into psychedelic therapies through partnerships between various bodies.

19 reports, 10 independent Updated Sep 14
Gone quiet Reached 4 outlets in its first 24 hours
Reports
19
Developments
5
Repetition
84%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 10 independent outlets

An Executive Order has been issued mandating accelerated research into psychedelic therapies through partnerships between various bodies.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. FDA and DEA are collaborating to accelerate investigational treatment pathways for psychedelic drugs.1 source
  2. Cohoba promotes the therapeutic use of mind-altering substances as an executive order pushes for expedited drug approvals.Sub-event
  3. Trump wanted FDA approval for psychedelic therapies. Heidi Overton advised on policy regarding the executive order, which led to team submissions to the Domestic Policy Council.Sub-event
  4. Executive order accelerates review of psychedelic treatments.1 source
  5. Executive Order accelerates psychedelic therapy research involving FDA, HHS, and the administration.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
8 more outlets ran the same wire story